Efficacy and Safety in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Idelalisib and Rituximab in the Clinical Practice: a GIMEMA-ERIC Study

NCT03545035 · clinicaltrials.gov ↗
COMPLETED
Status
104
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto

Collaborators